BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3012745)

  • 1. [Activation of latent infections caused by the Epstein-Barr virus in systemic lupus erythematosus].
    Anan'eva LP; Alekberova ZS; Nasonova VA; Stepina VN
    Revmatologiia (Mosk); 1986; (1):39-43. PubMed ID: 3012745
    [No Abstract]   [Full Text] [Related]  

  • 2. Enhancement of Epstein-Barr virus antibody production in systemic lupus erythematosus patients.
    Stancek D; Robenský J
    Acta Virol; 1979 Mar; 23(2):168-9. PubMed ID: 39442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Epstein-Barr virus and its role in various rheumatic diseases].
    Anan'eva LP; Alekberova ZS; Barinskii IF; Nasonova VA
    Ter Arkh; 1983; 55(7):140-6. PubMed ID: 6312625
    [No Abstract]   [Full Text] [Related]  

  • 4. High titer of antibody to the Epstein-Barr virus membrane antigen in sera from patients with rheumatoid arthritis and systemic lupus erythematosus.
    Yokochi T; Yanagawa A; Kimura Y; Mizushima Y
    J Rheumatol; 1989 Aug; 16(8):1029-32. PubMed ID: 2555505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus and systemic lupus erythematosus.
    James JA; Harley JB; Scofield RH
    Curr Opin Rheumatol; 2006 Sep; 18(5):462-7. PubMed ID: 16896283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactions of sera from patients with rheumatoid arthritis, systemic lupus erythematosus and infectious mononucleosis to Epstein-Barr virus-induced polypeptides.
    Sculley DG; Sculley TB; Pope JH
    J Gen Virol; 1986 Oct; 67 ( Pt 10)():2253-8. PubMed ID: 3020161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-cell control of herpesvirus infections: lessons from the Epstein-Barr virus.
    Rickinson AB
    Prog Brain Res; 1983; 59():189-202. PubMed ID: 6320264
    [No Abstract]   [Full Text] [Related]  

  • 8. Molecular mimicry in systemic lupus erythematosus.
    Agmon-Levin N; Blank M; Paz Z; Shoenfeld Y
    Lupus; 2009 Nov; 18(13):1181-5. PubMed ID: 19880565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Epstein-Barr virus antibodies in systemic lupus erythematosus.
    Origgi L; Perego R; Hu C; Bertetti E; D'Agostino P; Asero R; Riboldi P
    Boll Ist Sieroter Milan; 1988; 67(2):116-22. PubMed ID: 2852506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus-specific cytoskeletal early antigen in EBV-transformed cell lines.
    Sairenji T; Nguyen QV; Woda B; Humphreys RE
    AIDS Res; 1986 Dec; 2 Suppl 1():S57-60. PubMed ID: 3030348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antibody formation against specific Epstein-Barr virus antigens in infectious mononucleosis with tonsillectomy in the acute phase of the disease].
    Sauerbrei A; Sprössig M; Wutzler P; Färber I; Schweizer H; Swoboda R; Wilke J
    Laryngol Rhinol Otol (Stuttg); 1983 Apr; 62(4):170-4. PubMed ID: 6191167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunopathology of infectious mononucleosis and other complications of Epstein-Barr virus infections.
    Purtilo DT
    Pathol Annu; 1980; 15(Pt 1):253-99. PubMed ID: 6255399
    [No Abstract]   [Full Text] [Related]  

  • 13. Epstein-Barr virus infection in heart and heart-lung transplant recipients: incidence and clinical impact.
    Gray J; Wreghitt TG; Pavel P; Smyth RL; Parameshwar J; Stewart S; Cary N; Large S; Wallwork J
    J Heart Lung Transplant; 1995; 14(4):640-6. PubMed ID: 7578169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus (herpes-type virus) antibodies in connective tissue diseases.
    Stevens DA; Stevens MB; Newell GR; Levine PH; Waggoner DE
    Arch Intern Med; 1972 Jul; 130(1):23-8. PubMed ID: 4338539
    [No Abstract]   [Full Text] [Related]  

  • 15. Immune response to different sequences of the EBNA I molecule in Epstein-Barr virus-related disorders and in autoimmune diseases.
    Marchini B; Dolcher MP; Sabbatini A; Klein G; Migliorini P
    J Autoimmun; 1994 Apr; 7(2):179-91. PubMed ID: 7518683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-barr-virus nuclear antigen.
    Vonka V; Hirsch I
    Prog Med Virol; 1982; 28():145-79. PubMed ID: 6283600
    [No Abstract]   [Full Text] [Related]  

  • 17. [Analysis of viral capsid anti-antigen antibodies of the Epstein Barr virus in infectious mononucleosis. Comparative evaluation of a fluorescence method with classic methods].
    Picerno G; Lari M; Fregoso F; Musmanno G
    Quad Sclavo Diagn; 1983 Dec; 19(4):489-98. PubMed ID: 6330785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Leukocyte migration inhibition elicited by Epstein-Barr virus antigen. Reaction potential in infectious mononucleosis as well as in states of immune deficiency and immunosuppression].
    Szigeti R; Klein E; Masucci MG; Ernberg I; Masucci G; Svedmyr E; Klein G
    Orv Hetil; 1982 May; 123(20):1217-21. PubMed ID: 6287380
    [No Abstract]   [Full Text] [Related]  

  • 19. [Antibodies against non-structural antigens of Epstein-Barr virus in children with infectious mononucleosis].
    Najberg G
    Med Dosw Mikrobiol; 1983; 35(1):55-9. PubMed ID: 6314071
    [No Abstract]   [Full Text] [Related]  

  • 20. The Epstein-Barr virus (EBV) in human pathology. Results of a serological investigation of a hospital population.
    Dalens M; Didier J; Pris J; Enjalbert L
    Biomedicine; 1973 Jul; 18(4):336-45. PubMed ID: 4139980
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.